Clinical trial
Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
NCT06054529 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 11, 2023
- Completion date
- December 31, 2025
- Enrollment
- 2 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glioblastoma multiforme